While not approved for human or veterinary use, AHK-Cu continues to generate strong interest as a research compound across cellular and tissue model studies
This includes, but is not limited to, injections into joints, bursa, or the epidural space , which are all routes of administration that were previously allowed
When this hormone binds to receptors in the brain, pancreas, stomach, and elsewhere, several things happen: Appetite is significantly reduced, with many patients reporting a dramatic decrease in food cravings Gastric emptying slows, meaning food stays in the stomach longer and fullness is sustained after smaller meals Blood sugar regulation improves, reducing the energy spikes and dips that typically drive overeating Interest in high-calorie and highly processed foods often reduces, an effect many patients describe as the food noise quietening Mounjaro (tirzepatide) adds a second mechanism by also activating the GIP receptor
This product is intended for laboratory and research purposes only not for human or veterinary use Reviews There are no reviews yet
